CLASSIFICATION: MITOCHONDRIAL-DERIVED PEPTIDE
ACTIVE SUBSTANCE: MOTS-C
FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: ~ 3-4 HOURS
DOSAGE: 5-10 MG/WEEK (SPLIT INJECTIONS)
MANUFACTURER: AXIOLABS
Axiolabs MOTS-c 10 mg is a mitochondrial-derived peptide encoded by the mitochondrial genome, distinct from nuclear-encoded peptides. Each 2 mL vial contains 10 mg of lyophilized MOTS-c, ready for reconstitution for research applications involving metabolic regulation, insulin sensitivity, and cellular energy homeostasis.
MOTS-c has gained significant attention in metabolic research due to its ability to influence AMPK activation and improve insulin sensitivity in animal models. Unlike traditional growth hormone peptides or GHRPs, MOTS-c operates through mitochondrial signaling pathways. For researchers studying metabolic function, this peptide represents a unique tool. Explore similar research compounds like Ipamorelin 5 mg or GHK-CU 50 mg.
MOTS-c is one of the few known peptides encoded by mitochondrial DNA (mtDNA) rather than nuclear DNA. It translocates to the nucleus under metabolic stress conditions, influencing gene expression related to metabolism and inflammation. This distinct origin and mechanism sets it apart from synthetic peptides or hormone analogs.
For performance-focused research, MOTS-c is often studied in the context of metabolic adaptation and energy expenditure. The 10 mg dosage provides sufficient material for extended protocols investigating chronic metabolic interventions. Researchers may also combine MOTS-c with other metabolic research tools to evaluate comprehensive pathway interactions.
Axiolabs MOTS-c 10 mg is intended for laboratory research only. Not for human consumption or clinical use.
External research on MOTS-c's mechanisms can be explored via PubMed for peer-reviewed studies.
For laboratory research use only. Not for human consumption. Reconstitution and handling must be performed by qualified personnel using sterile techniques.
The standard reconstitution yields a concentration of approximately 2-5 mg/mL depending on the volume used. For precise dosing, researchers should calculate based on desired mg per injection volume.
In animal models, MOTS-c is often administered at dosages ranging from 5-10 mg per week, typically divided into 2-3 injections. Subcutaneous injection is the standard route for systemic metabolic research. Due to its short half-life, frequent administration may be required for sustained pathway activation studies.
MOTS-c is often studied in isolation due to its unique mitochondrial signaling pathway. However, some protocols combine it with other metabolic modulators to evaluate synergistic effects on energy homeostasis. For comprehensive metabolic research, explore our range of research peptides.
Note: Dosages mentioned are for research purposes only. Individual response varies in animal models. Always follow institutional animal care guidelines when conducting in vivo research.
Third-party analytical testing (COA) for Axiolabs MOTS-c 10 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.
This product is supplied through the official Axiolabs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Store Axiolabs MOTS-c 10 mg lyophilized powder in a cool, dry place away from direct light and moisture. Prior to reconstitution, the unopened vial should be kept at controlled room temperature (15-25°C) or refrigerated (2-8°C) for long-term storage. Do not freeze the lyophilized powder, as this may damage the peptide structure.
After reconstitution with bacteriostatic water, the solution must be stored at 2-8°C (refrigerator) and used within 30 days to maintain peptide integrity. Avoid repeated freeze-thaw cycles. Do not use if the solution appears cloudy or contains particulates, or if the vial seal is compromised.
Keep out of reach of children and unauthorized personnel. Follow standard laboratory safety protocols when handling peptides.
Proper storage conditions help maintain research-grade purity and consistent performance across the product's shelf life.
MOTS-c is studied for its role in metabolic regulation, insulin sensitivity, AMPK activation, and cellular energy homeostasis. It is a mitochondrial-derived peptide with unique signaling properties.
Add 2-5 mL of bacteriostatic water to the 10 mg vial, swirling gently until fully dissolved. The resulting concentration will be approximately 2-5 mg/mL depending on the volume used.
In animal studies, dosages often range from 5-10 mg per week, typically divided into 2-3 subcutaneous injections. Dosing should be scaled appropriately for the research model and study objectives.
MOTS-c is encoded by mitochondrial DNA rather than nuclear DNA, making it distinct from most research peptides. It influences metabolic pathways through AMPK activation rather than growth hormone release pathways.
Third-party COA testing is currently pending. Axiolabs is committed to publishing batch-specific lab reports as soon as analytical testing is completed and verified.
Please log in to write MOTS-C 10 MG review.
CLASSIFICATION: MITOCHONDRIAL-DERIVED PEPTIDE
ACTIVE SUBSTANCE: MOTS-C
FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: ~ 3-4 HOURS
DOSAGE: 5-10 MG/WEEK (SPLIT INJECTIONS)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO IMPACT
HEPATOTOXICITY: NONE
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA